Literature DB >> 12408967

Widely spaced alternative promoters, conserved between human and rodent, control expression of the Opitz syndrome gene MID1.

Josette Renée Landry1, Dixie L Mager.   

Abstract

Mutations in the gene MID1 are responsible for the X-linked form of Opitz syndrome, a genetic disorder that primarily affects the development of midline structures. Several mRNA isoforms with variant 5' ends have been reported for MID1, suggesting the presence of alternative transcription initiation sites. However, the genomic organization and expression pattern of the heterogeneous MID1 5'-untranslated regions (UTRs), as well as the promoter regions regulating their transcription, have not been determined. We now report the characterization of alternative MID1 first exons and their associated promoters in human and other species. Multiple transcription initiation sites, dispersed over 250 kb on Xp22, were found to give rise to five MID1 isoforms in human that differed in their 5'-UTRs, but contained identical coding sequence. These alternative MID1 transcripts showed distinct expression patterns with the most 5' first exon being adipose-specific and another exon being placenta-selective, whereas other 5'-UTRs seemed to be ubiquitous. Consistent with the expression data, the putative promoter regions upstream of the variant first exons also varied in their strength and tissue specificity in transfection experiments. Similar to the human gene, heterogeneous Mid1 isoforms were also identified in mouse and rat by 5'-RACE, which revealed that three of the five alternative first exons isolated in human are also used in rodent. Comparison of MID1 promoter regions from several mammals indicated a high level of identity suggesting evolutionary conservation. Together, these results suggest that alternative promoters are important in the complex transcriptional regulation of MID1 expression in several species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12408967

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Regulation of the MID1 protein function is fine-tuned by a complex pattern of alternative splicing.

Authors:  Jennifer Winter; Tanja Lehmann; Sybille Krauss; Alexander Trockenbacher; Zofia Kijas; John Foerster; Vanessa Suckow; Marie-Laure Yaspo; Andreas Kulozik; Vera Kalscheuer; Rainer Schneider; Susann Schweiger
Journal:  Hum Genet       Date:  2004-03-31       Impact factor: 4.132

2.  Increasing alternative promoter repertories is positively associated with differential expression and disease susceptibility.

Authors:  Song Liu
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

3.  Hypomethylation of functional retrotransposon-derived genes in the human placenta.

Authors:  Erin C Macaulay; Robert J Weeks; Simon Andrews; Ian M Morison
Journal:  Mamm Genome       Date:  2011-08-27       Impact factor: 2.957

Review 4.  The MID1 gene product in physiology and disease.

Authors:  Rossella Baldini; Martina Mascaro; Germana Meroni
Journal:  Gene       Date:  2020-04-10       Impact factor: 3.688

5.  An endogenous retroviral long terminal repeat is the dominant promoter for human beta1,3-galactosyltransferase 5 in the colon.

Authors:  Catherine A Dunn; Patrik Medstrand; Dixie L Mager
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-08       Impact factor: 11.205

6.  Reduced Mid1 Expression and Delayed Neuromotor Development in daDREAM Transgenic Mice.

Authors:  Mara Dierssen; Laura Fedrizzi; Rosa Gomez-Villafuertes; María Martinez de Lagran; Alfonso Gutierrez-Adan; Ignasi Sahún; Belen Pintado; Juan C Oliveros; Xose M Dopazo; Paz Gonzalez; Marisa Brini; Britt Mellström; Ernesto Carafoli; Jose R Naranjo
Journal:  Front Mol Neurosci       Date:  2012-05-03       Impact factor: 5.639

7.  Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.

Authors:  Jennifer Winter; Melanie Kunath; Stefan Roepcke; Sven Krause; Rainer Schneider; Susann Schweiger
Journal:  BMC Mol Biol       Date:  2007-11-15       Impact factor: 2.946

8.  Widely variable endogenous retroviral methylation levels in human placenta.

Authors:  Daphne Reiss; Ying Zhang; Dixie L Mager
Journal:  Nucleic Acids Res       Date:  2007-07-07       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.